Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

Clinical and Genomic Analysis of Metastatic Disease Progression in a Background of Biochemical Recurrence

Go back to Resources

Clinical and Genomic Analysis of Metastatic Disease Progression in a Background of Biochemical Recurrence

Authors:

Secondary:

Location:

URL:

Go back to Resources

Characterization of Reticular Drusen and Association with Age Macular Degeneration through Multiple Imaging Modalities

Go back to Resources

Characterization of Reticular Drusen and Association with Age Macular Degeneration through Multiple Imaging Modalities

Authors:

Secondary:

Location:

URL:

Keywords:

Abstract:

Go back to Resources

An Assessment of the Perceived Benefits and Challenges of Participating in a Practice-based Research Network

Go back to Resources

An Assessment of the Perceived Benefits and Challenges of Participating in a Practice-based Research Network

Authors:

Secondary:

Volume:

Pagination:

URL:

Abstract:

Go back to Resources

A Phase II Study of Allogeneic Transplantation for Older Patients with AML in First Complete Remission Using a Reduced Intensity Conditioning Regimen: Results from CALGB 100103/BMT CTN 0502

Go back to Resources

A Phase II Study of Allogeneic Transplantation for Older Patients with AML in First Complete Remission Using a Reduced Intensity Conditioning Regimen: Results from CALGB 100103/BMT CTN 0502

Authors:

Secondary:

Location:

URL:

Go back to Resources

A Phase I Double Blind, Placebo-Controlled, Randomized Study of a Multigenic HIV-1 Adenovirus Subtype 35 Vector Vaccine in Healthy Uninfected Adults

Go back to Resources

A Phase I Double Blind, Placebo-Controlled, Randomized Study of a Multigenic HIV-1 Adenovirus Subtype 35 Vector Vaccine in Healthy Uninfected Adults

Authors:

Secondary:

Volume:

Pagination:

URL:

Abstract:

Go back to Resources

A Longitudinal Trial Comparing Chloroquine as Monotherapy or In Combination with Artesunate, Azithromycin or Atovaquone-Proguanil to Treat Malaria

Go back to Resources

A Longitudinal Trial Comparing Chloroquine as Monotherapy or In Combination with Artesunate, Azithromycin or Atovaquone-Proguanil to Treat Malaria

Authors:

Secondary:

Volume:

Pagination:

URL:

Abstract:

Go back to Resources

"En Face" OCT Imaging of the IS/OS Junction Line in Type 2 Idiopathic Macular Telangiectasia

Go back to Resources

"En Face" OCT Imaging of the IS/OS Junction Line in Type 2 Idiopathic Macular Telangiectasia

Authors:

Secondary:

Volume:

Pagination:

URL:

Abstract:

Go back to Resources

Web-Based, Psychosocial Treatment for Substance Use Disorders in Community Treatment Settings

Go back to Resources

Web-Based, Psychosocial Treatment for Substance Use Disorders in Community Treatment Settings

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Acute Rejection Characteristics From a Prospective, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial of Early Corticosteroid Withdrawal

Go back to Resources

Acute Rejection Characteristics From a Prospective, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial of Early Corticosteroid Withdrawal

Authors:

Secondary:

Volume:

Pagination:

URL:

Abstract:

Go back to Resources

A Phase 1 Study of Heat/Phenol Killed, E. coli-Encapsulated, Recombinant Modified Peanut Proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the Treatment of Peanut Allergy

Go back to Resources

A Phase 1 Study of Heat/Phenol Killed, E. coli-Encapsulated, Recombinant Modified Peanut Proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the Treatment of Peanut Allergy

Authors:

Secondary:

Volume:

Pagination:

Location:

Publisher:

URL:

Abstract:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 194
  • Page 195
  • Page 196
  • Page 197
  • Current page 198
  • Page 199
  • Page 200
  • Page 201
  • Page 202
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions